Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 7/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | MMP8 | P22894 | 1/20 | 0.32 |
| ▸ | MMP13 | P45452 | 1/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL9662368 | 0.97 | RAPGEF4 (0.41) | RAPGEF4ALDH1A1KDM4ELMNAGAA | |
| Silver SCHEMBL31010581 | 0.97 | RAPGEF4 (0.41) | RAPGEF4ALDH1A1KDM4ELMNAGAA | |
| SCHEMBL31325570 | 0.97 | RAPGEF4 (0.41) | RAPGEF4ALDH1A1KDM4ELMNAGAA | |
| SCHEMBL8773546 | 0.97 | RAPGEF4 (0.41) | RAPGEF4ALDH1A1KDM4ELMNAGAA | |
| Bromide SCHEMBL3679642 | 0.97 | RAPGEF4 (0.41) | RAPGEF4ALDH1A1KDM4ELMNAGAA | |
| SCHEMBL19058224 | 0.87 | CYP1A2 (0.41) | RAPGEF4ALDH1A1TSHRCYP1A2CYP2A6 | |
| SCHEMBL15077511 | 0.87 | RAPGEF4 (0.43) | RAPGEF4ALDH1A1KDM4ELMNAGAA | |
| SCHEMBL8585774 | 0.84 | RAPGEF4 (0.33) | RAPGEF4 | |
| SCHEMBL18863402 | 0.81 | TP53 (0.39) | RAPGEF4ALDH1A1TP53TDP1 | |
| SCHEMBL28373345 | 0.81 | RAPGEF4 (0.42) | RAPGEF4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1038 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260128365-A1 | POSITIVE ELECTRODE SLURRY FOR ALL-SOLID-STATE BATTERY AND METHOD FOR PRODUCING SAME, ALL-SOLID-STATE BATTERY PRODUCED USING SAME | SAMSUNG SDI CO LTD (KR) | 2026-05-07 | — | — | US | claimed |
| EP-4738511-A1 | POSITIVE ELECTRODE SLURRY FOR ALL-SOLID-STATE BATTERY AND METHOD FOR PRODUCING SAME, ALL-SOLID-STATE BATTERY PRODUCED USING SAME | SAMSUNG SDI CO., LTD. (KR) | 2026-05-06 | — | — | EP | claimed |
| EP-4590766-A1 | PHOTORESIN FORMULATIONS AND USE THEREOF FOR VOLUMETRIC ADDITIVE MANUFACTURING | National Research Council of Canada (CA) | 2025-07-30 | — | — | EP | claimed |
| WO-2025132825-A1 | 1H-IMIDAZO[4,5-C]QUINOLINE METAL-BASED COMPLEXES USEFUL AS MEDICAMENTS | FUNDACIÓN DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC (ES) | 2025-06-26 | — | — | WO | claimed |
| CN-115702041-B | Hydroformylation catalyst system with synthesis gas substitute | V.马内菲尔斯 | 2025-03-18 | — | — | CN | claimed |
| CN-119300612-A | Perovskite surface defect passivation material, passivation unit, preparation method and battery | 天合光能股份有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-111936117-B | Covalent treatment of keratin-containing materials | 生活实验公司 | 2025-01-07 | — | — | CN | claimed |
| CN-118932196-A | Method for separating rhenium and molybdenum by utilizing quaternary phosphonium salt modified material | 武汉轻工大学 | 2024-11-12 | — | — | CN | claimed |
| CN-112040926-B | Covalent treatment of keratin-containing materials with thiols | 生活实验公司 | 2024-07-02 | — | — | CN | claimed |
| CN-117860615-A | Covalent treatment of keratin-containing materials | 生活实验公司 | 2024-04-12 | — | — | CN | claimed |
| WO-2000034344-A1 | IN MOLD ADDITION POLYMERIZATION OF NORBORNENE-TYPE MONOMERS USING GROUP 10 METAL COMPLEXES | THE B.F.GOODRICH COMPANY (US) | 2000-06-15 | — | — | WO | claimed |
| WO-2000020472-A1 | CATALYST AND METHODS FOR POLYMERIZING CYCLOOLEFINS | THE B.F. GOODRICH COMPANY (US) | 2000-04-13 | — | — | WO | claimed |
| US-5830820-A | Olefin polymerization catalyst and olefin polymerization process | TOSOH CORPORATION (JP) | 1998-11-03 | — | — | US | claimed |
| EP-0658576-B1 | Olefin polymerization catalyst and olefin polymerization process | TOSOH CORP (JP) | 1998-07-29 | — | — | EP | claimed |
| US-5693820-A | Ruthenium complexes with a chiral, bidentate phosphine/oxazoline ligand for enantioselective transfer hydrogenation of prochiral ketones | BASF AKTIENGESELLSCHAFT (DE) | 1997-12-02 | — | — | US | claimed |
| EP-0780157-A1 | Ruthenium complex with chiral bidentate phosphinoxazolin ligands for the enantioselective transfer hydrogenation of prochiral cetons | BASF AKTIENGESELLSCHAFT (DE) | 1997-06-25 | — | — | EP | claimed |
| US-5600034-A | HEAT TREATING DIALLYL ETHERS IN PRESENCE OF CATALYST CONTAINING PALLADIUM AND PHOSPHORUS COMPOUNDS | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-02-04 | — | — | US | claimed |
| US-5583271-A | Method for continuously producing alkadienols | MITSUBISHI CHEMICAL CORPORATION (JP) | 1996-12-10 | — | — | US | claimed |
| EP-0376103-B1 | A 2-acylamino-5-halogenated-cinnamic acid derivative and method for its production | NIPPON KAYAKU KK (JP) | 1994-04-20 | — | — | EP | claimed |
| EP-0376103-A1 | A 2-acylamino-5-halogenated-cinnamic acid derivative and method for its production | Nippon Kayaku Kabushiki Kaisha (JP) | 1990-07-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260128365-A1 | POSITIVE ELECTRODE SLURRY FOR ALL-SOLID-STATE BATTERY AND METHOD FOR PRODUCING SAME, ALL-SOLID-STATE BATTERY PRODUCED USING SAME | TST, SLC6A12, NCS1 | RAPGEF4 2647/4885ALDH1A1 3107/4885KDM4E 197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.